academic article

• Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer. 2016
• Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes. 2016
• Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity..  The American journal of pathology.  :-. 2016
• Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors. 2016
• PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. 2015
• Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings..  Journal of controlled release : official journal of the Controlled Release Society.  170:233-241. 2013
• Luminescent silica nanoparticles for cancer diagnosis..  Current medicinal chemistry.  20:2195-2211. 2013